NervGen Pharma Corp.
General ticker "NGENF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $170.3M (TTM average)
NervGen Pharma Corp. follows the US Stock Market performance with the rate: 30.0%.
Estimated limits based on current volatility of 4.2%: low 4.09$, high 4.44$
Factors to consider:
- Current price 48.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.28$, 2.98$]
- 2025-12-31 to 2026-12-31 estimated range: [1.08$, 2.58$]
Financial Metrics affecting the NGENF estimates:
- Positive: with PPE of -8.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.32 <= 0.33
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0.03 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term NGENF quotes
Long-term NGENF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | CA$0.00MM | CA$0.00MM |
| Operating Expenses | CA$17.78MM | CA$24.93MM |
| Operating Income | CA$-17.78MM | CA$-24.93MM |
| Non-Operating Income | CA$-4.61MM | CA$0.93MM |
| R&D Expense | CA$8.05MM | CA$15.73MM |
| Income(Loss) | CA$-22.38MM | CA$-24.01MM |
| Profit(Loss)* | CA$-22.38MM | CA$-24.01MM |
| Stockholders Equity | CA$-2.01MM | CA$2.58MM |
| Assets | CA$13.24MM | CA$19.49MM |
| Operating Cash Flow | CA$-11.30MM | CA$-16.84MM |
| Capital expenditure | CA$0.14MM | CA$0.00MM |
| Investing Cash Flow | CA$-0.14MM | CA$0.06MM |
| Financing Cash Flow | CA$0.77MM | CA$22.70MM |
| Earnings Per Share** | CA$-0.38 | CA$-0.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.